NCT00096811No Longer Available不适用
A Treatment Use Protocol of Entecavir in Subjects With Chronic Hepatitis B Infection Who Have Failed or Who Are Intolerant of Available Therapies
Bristol-Myers Squibb1 个研究点 分布在 1 个国家开始时间: 2003年9月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
- 发起方
- 试验地点
- 1
研究概览
简要总结
The purpose of this clinical research study is to provide entecavir to subjects with chronic Hepatitis B infection who have failed or who have demonstrated intolerance of marketed therapies or for those in whom use of these agents is contraindicated and that have no other available treatment options.
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 16 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Hepatitis B Early Access Program
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Entecavir for Chronic Hepatitis BEntecavir for Chronic Hepatitis B PatientsNCT01323452Foundation for Liver Research418
已完成
4 期
A open-label study of entecavir for chronic hepatitis B to determine the optimum duration of administratiochronic hepatitis BJPRN-UMIN000000644Gunma Liver Study Group70
Unknown
4 期
Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver TransplantationLiver TransplantationHepatitis BNCT02417207Third Affiliated Hospital, Sun Yat-Sen University60
已完成
3 期
Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus InfectionHepatitis B, ChronicNCT00395018Bristol-Myers Squibb109
已完成
4 期
Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) InfectionHepatitis B InfectionNCT00371150Bristol-Myers Squibb131